Systematic review of incretin therapy during peri-operative and intensive care

BACKGROUND: Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are incretin hormones. By lowering blood glucose in a glucose-dependent manner, incretin-based therapies represent a novel and promising intervention to treat hyperglycaemia in hospital settings. We perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulst, Abraham H, Plummer, Mark P, Hollmann, Markus W, DeVries, J Hans, Preckel, Benedikt, Deane, Adam M, Hermanides, Jeroen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236901/
https://www.ncbi.nlm.nih.gov/pubmed/30428906
http://dx.doi.org/10.1186/s13054-018-2197-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236901/
https://www.ncbi.nlm.nih.gov/pubmed/30428906
http://dx.doi.org/10.1186/s13054-018-2197-4

Ejemplares similares